Look Out Leukemia, TKIs to the Rescue: Updates in the Management of AML
The purpose of this learning activity is to provide a thorough overview of the management of AML, with a focus on the agents newly approved in the last decade (i.e. their mechanism of action, side effects, clinical pearls, literature review etc.). After participating in this educational activity, pharmacists will understand the role these agents have in the management of AML.
- Describe the pathophysiology, cytogenetics, and molecular abnormalities associated with acute myeloid leukemia
- Differentiate between historical treatment options and the novel agents approved for the management of acute myeloid leukemia
- Evaluate the recent literature regarding recently approved agents for acute myeloid leukemia
- Review the mechanisms of action, dosing, side effect profile, and clinical pearls associated with the novel agents
- 1.00 ACPE Pharmacist